Wolf prize granted to scientists working on gene editing technology
Israel's prestigious Wolf Prize has been granted to Jennifer Doudna and Emmanuelle Charpentier for their work in developing the revolutionary gene-editing tool CRISPR. This technology may allow scientists to permanently get rid of gene-based disease although it is still in the early stages of testing. It is unclear when the technology will be available to the public.
science health israel gene-editing biology
HaaretzRelated Articles
Intel confirms acquisition of Moovit in a $900 million deal
American multinational corporation and technology company Intel confirmed today that the company is acquiring an Israeli transportation and mobility startup Moovit in order to grow its automotive division. Moovit analyses urban traffic patterns and provides transportation recommendations with a specific focus on public transit. Intel is paying around $840 million for the startup
acquisition israel intel startup moovit
Techcrunch
Detroit to begin using Abbot Labs' new 5-minute coronavirus test
Detroit is going to become the first city to use the new Abbot Labs 5 minute coronavirus test. The mayor has said that first responders will have access to the test and they will be available within the next 24 hours. The test requires very little equipment and can produce results faster than any other available method.
test health economy death coronavirus quarantine lab money detroit abbot-labs
TechCrunch
Video Conferencing apps experience record levels of demand
Due to the lockdown that has taken place in numerous countries across the planet, more and more people are working via video conference apps and software. Since people are unable to leave their homes, video conference apps have gotten 62 million new downloads this week, a new world record.
internet health economy death coronavirus quarantine money zoom skype video-conference voice-chat communication
TechCrunch
Johnson & Johnson to fund $1 billion coronavirus vaccine research
Pharmaceutical giant Johnson & Johnson has partnered up with the US Biomedical Advanced Research and Development Authority to fun $1 billion's worth of coronavirus vaccine and treatment research. The company intends to provide 1 billion doses of the vaccine worldwide and will likely start clinical trials by September. They intend to have it ready by 2021.
health research economy vaccine death coronavirus quarantine money covid-19 johnson-johnson
TechCrunch